Qiagen宣布新任命，竟然是他倆！

　　據Qiagen（凱杰）2023年Q3季度財務報告顯示，凱杰執行委員會領導層將發生變動。

　　Jean-Pascal Viola一直領導著QIAGEN的分子診斷業務，然而從11月1日起，他將正式擔任高級副總裁、企業戰略與業務發展主管間的執行委員會成員。

　　11月1日，Qiagen正式任命宣布Fernando Beils為高級副總裁、分子診斷業務領域主管和執行委員會成員。Fernando Beils在診斷行業擔任各種全球領導職務。在加入QIAGEN之前，是在賽默飛世爾科學公司(Thermo Fisher Scientific)擔任基因檢測解決方案業務副總裁兼總經理。在加入賽默飛世爾之前，他在西門子(Siemens)擔任商業、戰略和財務職位超過20年，最后擔任Siemens Healthineers分子診斷業務部門的全球主管，并獲得了EWA馬德里和該大學的工商管理學位莫斯巴赫商學院。

Qiagen官宣原文如下：

　　Leadership changes in Executive Committee

　　After leading the Molecular Diagnostics business of QIAGEN since 2020, Jean-Pascal Viola will takeon a new role as of November 1, 2023, as Senior Vice President, Head of Corporate Strategy &Business Development and member of the Executive Committee. Fernando Beils has been appointedas his successor as Senior Vice President, Head of the Molecular Diagnostics Business Area andmember of the Executive Committee, also effective November 1, 2023. He joins QIAGEN after havingworked in various global leadership roles in the diagnostics industry, and most recently serving as VicePresident and General Manager of the Genetic Testing Solutions Business at Thermo Fisher ScientificPrior to his time at Thermo Fisher, he spent over two decades at Siemens in commercial, strategy andfinance roles, and in his last role as Global Head of the Molecular Diaanostics Business Unit at SiemensHealthineers. He earned a degree in Business Administration from EWA Madrid and the UniversityMosbach School of Business.